Patents/Assignees

GLYCOLYSIS BIOMED CO., Ltd.

1 patent in portfolio

US11564908utility2023
Beta-lactam Compounds or Salts Thereof for Use in Long-acting Prevention or Treatment of a Glucose Metabolism Disorder
0 cites